300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Music
Food and Beverage
Publishing
Manufacturing
Digital Media
Art
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Real Estate
Non Profit
Internet
Sporting Goods
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Burkina Faso
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
South Africa
United Kingdom
France
Georgia
Ghana
Denmark
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Philippines
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Barbados
Jordan
Cyprus
Austria
Ethiopia
Qatar
Azerbaijan
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Jersey
Belize
Bahrain
Finland
Hungary
Italy
Belarus
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Bullet Time Ventures II

VC Fund

Boulder, United States

Bullet Time Ventures II is a micro venture capital firm that finances early-stage startups.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries Bullet Time Ventures II invests in

FitnessMedicalHealth CareMedical DeviceProfessional Services

Stages Bullet Time Ventures II invests in

Venture - Series Unknown

Countries Bullet Time Ventures II invests in

Mexico

Investment Focus

Industry

  • Fitness 1 (100%)
  • Medical 1 (100%)
  • Health Care 1 (100%)
  • Medical Device 1 (100%)
  • Professional Services 1 (100%)
See all 6 industries →

Investments

CompanyDescriptionRoundLinks
Oncovision Oncovision
Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry. $509.8K / Venture - Series Unknown / Jan 18, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Music
Food and Beverage
Publishing
Manufacturing
Digital Media
Art
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Real Estate
Non Profit
Internet
Sporting Goods
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Burkina Faso
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
South Africa
United Kingdom
France
Georgia
Ghana
Denmark
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Philippines
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Barbados
Jordan
Cyprus
Austria
Ethiopia
Qatar
Azerbaijan
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Jersey
Belize
Bahrain
Finland
Hungary
Italy
Belarus
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Bullet Time Ventures II invest in?

Bullet Time Ventures II invests primarily in Fitness, Medical and Health Care startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Mexico. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Bullet Time Ventures II last invest?

The most recent investment recorded for Bullet Time Ventures II closed in Jan 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Bullet Time Ventures II Find emails